LRP1 and atherosclerosis: Cumulative evidence indicates that the ectodomain of LRP-1 undergoes proteolytic cleavage at the cell surface, in several pathological conditions, including atherosclerosis, neuroinflammation, Alzheimer’s disease, lung inflammation and acute respiratory distress syndrome (ARDS) [33,34,35,36,37,38].